Back
TC BioPharm (Holdings) PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
7
TCBP
TC BioPharm (Holdings) PLC
Last Price:
1.20
Seasonality Move:
-61.5%
Sell
30
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.85
Seasonality Move:
40.93%
Sell
7
TC BioPharm (Holdings) PLC (TCBP)
is a Sell
Is TC BioPharm (Holdings) PLC a Buy, Sell or Hold?
- The current TC BioPharm (Holdings) PLC [TCBP] share price is $1.29. The Score for TCBP is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- TCBP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.83. The Score for ADAP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCBP Stock Price Chart
What is TC BioPharm (Holdings) PLC's stock price today?
-
The TC BioPharm (Holdings) PLC share price today is $1.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCBP is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.83
The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
TCBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.16 | Sell |
| Relative Strength Index (14 RSI): | 26.12 | Sell |
| Chaikin Money Flow: | -216311 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 5.68) | Sell |
| Bollinger Bands (100): | (3.57 - 8.35) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 444283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.76 - 0.9) | Sell |
| Bollinger Bands (100): | (0.87 - 1.21) | Sell |
TCBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.45 | Sell |
| 20-day SMA: | 3.06 | Sell |
| 50-day SMA: | 4.85 | Sell |
| 200-day SMA: | 9.68 | Sell |
| 8-day EMA: | 1.65 | Sell |
| 20-day EMA: | 2.78 | Sell |
| 50-day EMA: | 4.35 | Sell |
| 200-day EMA: | 75.63 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.81 | Buy |
| 50-day SMA: | 0.96 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.78 | Buy |
| 20-day EMA: | 0.82 | Buy |
| 50-day EMA: | 0.91 | Sell |
| 200-day EMA: | 1.03 | Sell |
TC BioPharm (Holdings) PLC Earnings Growth & TCBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
TC BioPharm (Holdings) PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||